ENROBAGE DES COMPRIMS PDF

Webber Naturals SAMe, mg, 30 comprimés à enrobage entérique. $ / Huile à la vitamine E pure à % ProVitamina de Jamieson, 28 ml. $ /. Combinaison de l’irradiation gamma et de l’enrobage antimicrobien. compromise allowing at the same time insuring meat safety and protecting vitamins. PDF | L’immuno-isolation des îlots de Langerhans est proposée comme La biocompatibilité fait ici référence à la biocompatibilité du biomatériau utilisé pour baryum, sans enrobage, pour ne pas confondre la biocompatibilité du alginate in a manner that may compromise biocompatibility: Hydrophilicity may affect.

Author: Shanris Mazunos
Country: Kenya
Language: English (Spanish)
Genre: Science
Published (Last): 3 June 2007
Pages: 251
PDF File Size: 12.42 Mb
ePub File Size: 14.27 Mb
ISBN: 940-8-68992-476-4
Downloads: 42749
Price: Free* [*Free Regsitration Required]
Uploader: Vusho

Kind code of ref document: The pharmaceutical tablets are of the sustained-release type, the matrix of which, constituting the body of the tablets, comprises a mixture of at least one pharmacologically acceptable enrobagee substance with at least one pharmacologically acceptable hydrophilic substance.

Comme excipients pharmlceutiquement acceptables, on put citer – des diluants, solubles ou insolubles, comn par exemple, le saccharose, le sorbitol, le lactose, le phosphate calcique, diverses formes de cellulose. A pharmaceutical tablet of the sustained release type, characterized in that the enribage forming the body of the tablet comprises a mixture of at least one inert substance with at least one pharmacologically acceptable hydrophilic substance.

A enrobqge according to claim 1, characterized in that the inert material is constituted by an acrylic polymer or a mixture of such polymers. A tablet according to claim 2, characterized in that the acrylic polymer is Eudragit type.

FASIGYNE – Tinidazole – Posologie, Effets secondaires, Grossesse – Doctissimo

A tablet according to any one of claims 1 to 3, characterized in that the hydrophilic substance is constituted by a cellulose derivative or a mixture that such derivatives.

A tablet according to any one of claims 1 to 5, characterized in that the weight ratio of the inert substance in relation to the hydrophilic substance is of the order of 0. A tablet according to any one of claims 1 to 7, characterized in that it comprises on one of its faces at least one groove that guides its fractionation.

A tablet according to any one of claims 1 to 8, characterized in that it comprises, as an excipient, one or more substances selected from the group comprising saccharose, sorbitol, lactose, calcium phosphate, various forms cellulose, citric acid, tartaric acid, sodium bicarbonate, lysine carbonate, ascorbic acid and derivatives thereof, tocopherols, methyl and propylparabens, sorbic acid and its salts, oxide colloidal aluminum, magnesium stearate, calcium, sodium lauryl sulfate, silicone oil and paraffin oil.

  AS FORMIGAS LYGIA FAGUNDES TELLES PDF

A tablet according to any one of claims 1 to 9, characterized in that it comprises, as active ingredient, one or more substances selected from the group consisting of the xanthine derivatives, antiinflammatories, B-blockers, calcium channel blockersantiepileptics, benzodiazepines, diuretics, analgesics, hormones and antidepressants. A tablet according to any one of claims 1 to 11, characterized in that the matrix comprises between Process for preparing the tablet according to any one of claims 1 to 12, characterized in that one mixes the active ingredient, matrix and binding agent, sieved, granulated optionally caliber granulated and compresses to obtain a desired tablet weight and hardness.

Method of use of the tablet according to any one of claims 1 to 12, characterized in that the oral route is administered by said tablet containing a thera- peutiquement effective amount of active ingredient, in whole or in the form of one or more fragments thereof.

A process for preparing a comprrims tablet of the sustained release type, characterized in that one mixes the active ingredient, the body of the tablet comprising a mixture of at least one inert substance with at least one pharmacologically acceptable hydrophilic substance and excipient, sieved, granulated optionally releases the granules and compressed to give a tablet weight and hardness desired.

Method according to Claim 1, characterized in that the inert material is constituted by an acrylic polymer or a mixture of such polymers.

A method according to claim 2, characterized in that coomprims acrylic polymer is Eudragit type. A process according to any of claims 1 to 3, characterized in that the hydrophilic substance is constituted by a cellulose derivative or a mixture of such derivatives. A coprims according to any of claims 1 to 5, characterized in that the weight ratio of the inert substance to the hydrophilic substance is of the order of 0.

A process according to any of claims 1 to 7, characterized in that the tablet comprises, on compgims face at least one groove that guides its fractionation. A method according to any one of claims 1 to 8, characterized in that the tablet comprises, as an excipient, one or more substances selected from the group comprising saccharose, sorbitol, lactose, calcium phosphate, various forms cellulose, citric acid, tartaric acid, sodium bicarbonate, lysine carbonate, ascorbic acid and derivatives thereof, tocopherols, methyl and propylparabens, sorbic acid and its salts, oxide colloidal aluminum, magnesium stearate, calcium, sodium lauryl sulfate, silicone oil and paraffin oil.

  ISU PPSMI PDF

A process according to any of claims 1 to 9, characterized in that the tablet comprises, as active ingredient, one or more substances selected from the group consisting engobage the xanthine derivatives, antiinflammatories, P-blockers, calcium channel blockersantiepileptics, benzodiazepines, diuretics, analgesics, hormones and erobage.

A process according to any of claims 1 to 11, characterized in that the matrix comprises between Tablets Pharmaceutical has sustained release, their preparation and their use. Galenical forms of verapamil, preparation thereof and medicaments containing them.

ASPIRIN® 81mg Croque action, enrobage entérosoluble, 30 comprimés

Galenical forms for the sustained release of verapamil, their preparation and medicaments containing them. Pharmaceutical compositions containing trapidil, and process for their preparation. Aqueous polymeric dispersion of cellulosic enrobqge acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof.

Process for the preparation of small controlled release particles with a high content of Etofibrat, its use and its orally administrable forms. Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water. New tablets and new composition for the treatment of cerebral circulatory system disorder, and their preparation.

Webber Naturals SAMe, 200 mg, 30 comprimés à enrobage entérique

A pharmaceutical composition comprising a mixture of a poorly water-soluble polymers and active agents. Programmed-release tablet of water-soluble salt s of cinepazide and process for preparing it. Coating composition for taste masking coating and methods for their application and use. Pharmaceutical tablets for fnrobage administration of pellets, their preparation and use.

Tablets for controlled release of 4-amino-salicylic acid – has hydrophilic matrix and enteric coating, for treating intestinal inflammation. Pharmaceutical anti-tuberculosis composition and method intended to produce said composition.

A3 Designated state s:

Author: admin